These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 36585230
1. [miR-181c promotes the migration and angiogenesis of human A549 cells via targeting inhibition of reversion-inducing cysteine-rich protein with Kazal motifs (RECK)]. Liu C, Zhao F, Sun P, Han W, Hong M, Wu J, Zhang X. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Dec; 38(12):1084-1090. PubMed ID: 36585230 [Abstract] [Full Text] [Related]
2. MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression. Xin C, Buhe B, Hongting L, Chuanmin Y, Xiwei H, Hong Z, Lulu H, Qian D, Renjie W. FEBS J; 2013 Feb; 280(3):855-66. PubMed ID: 23176145 [Abstract] [Full Text] [Related]
3. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ. World J Gastroenterol; 2014 Dec 14; 20(46):17439-47. PubMed ID: 25516656 [Abstract] [Full Text] [Related]
4. microRNA-200b and microRNA-200c promote colorectal cancer cell proliferation via targeting the reversion-inducing cysteine-rich protein with Kazal motifs. Pan Y, Liang H, Chen W, Zhang H, Wang N, Wang F, Zhang S, Liu Y, Zhao C, Yan X, Zhang J, Zhang CY, Gu H, Zen K, Chen X. RNA Biol; 2015 Dec 14; 12(3):276-89. PubMed ID: 25826661 [Abstract] [Full Text] [Related]
5. STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Lin HY, Chiang CH, Hung WC. Br J Cancer; 2013 Aug 06; 109(3):731-8. PubMed ID: 23820254 [Abstract] [Full Text] [Related]
6. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Shen KH, Hung JH, Chang CW, Weng YT, Wu MJ, Chen PS. Chem Biol Interact; 2017 Apr 25; 268():129-135. PubMed ID: 28283413 [Abstract] [Full Text] [Related]
7. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells. Liu CT, Bi KW, Huang CC, Wu HT, Ho HY, S Pang JH, Huang ST. J Ethnopharmacol; 2017 Jan 20; 196():213-224. PubMed ID: 27993633 [Abstract] [Full Text] [Related]
8. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs. Zheng WP, Meng FL, Wang LY. Mol Cell Probes; 2020 Oct 20; 53():101572. PubMed ID: 32525042 [Abstract] [Full Text] [Related]
9. Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK. Jian Y, Xu CH, Li YP, Tang B, Xie SH, Zeng EM. Biosci Rep; 2019 Aug 30; 39(8):. PubMed ID: 31270250 [Abstract] [Full Text] [Related]
10. RECK (reversion-inducing cysteine-rich protein with Kazal motifs) regulates migration, differentiation and Wnt/β-catenin signaling in human mesenchymal stem cells. Mahl C, Egea V, Megens RT, Pitsch T, Santovito D, Weber C, Ries C. Cell Mol Life Sci; 2016 Apr 30; 73(7):1489-501. PubMed ID: 26459448 [Abstract] [Full Text] [Related]
11. Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus. Zhang X, Healy C, Nothnick WB. Endocrine; 2012 Aug 30; 42(1):97-106. PubMed ID: 22302680 [Abstract] [Full Text] [Related]
12. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty. Liu J, Chi D, Lu H, Zhang T, Yamakawa T. Ann Vasc Surg; 2015 Aug 30; 29(6):1293-9. PubMed ID: 26004948 [Abstract] [Full Text] [Related]
13. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease. Liu N, Cao Y, Zhu G. Arch Oral Biol; 2017 Mar 30; 75():62-67. PubMed ID: 28043014 [Abstract] [Full Text] [Related]
14. [miR-25 promotes cell proliferation by targeting RECK in human cervical carcinoma HeLa cells]. Qiu G, Fang B, Xin G, Wei Q, Yuan X, Wu D. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan 30; 31(1):40-3. PubMed ID: 25575057 [Abstract] [Full Text] [Related]
15. Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration. Siddesha JM, Valente AJ, Yoshida T, Sakamuri SS, Delafontaine P, Iba H, Noda M, Chandrasekar B. Cell Signal; 2014 May 30; 26(5):933-41. PubMed ID: 24447911 [Abstract] [Full Text] [Related]
16. Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK. Lei L, Huang Y, Gong W. Mol Cell Biochem; 2014 Feb 30; 387(1-2):171-6. PubMed ID: 24162673 [Abstract] [Full Text] [Related]
17. MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs. Fan X, Wang E, Wang X, Cong X, Chen X. Exp Mol Pathol; 2014 Apr 30; 96(2):242-9. PubMed ID: 24594117 [Abstract] [Full Text] [Related]
18. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T. Lung Cancer; 2007 Dec 30; 58(3):376-83. PubMed ID: 17714826 [Abstract] [Full Text] [Related]
19. MiR-25 promotes gastric cancer cells growth and motility by targeting RECK. Zhao H, Wang Y, Yang L, Jiang R, Li W. Mol Cell Biochem; 2014 Jan 30; 385(1-2):207-13. PubMed ID: 24078004 [Abstract] [Full Text] [Related]
20. MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma. Guan Y, Guo L, Zukerberg L, Rueda BR, Styer AK. Reprod Biol Endocrinol; 2016 Aug 17; 14(1):45. PubMed ID: 27530410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]